People with epilepsy frequently have cognitive impairment. The majority of cognitive
problems is influenced by a variety of interlinked factors, including the early onset of …

The developmental and epileptic encephalopathies encompass a group of rare syndromes
characterised by severe drug-resistant epilepsy with onset in childhood and significant …

Objectives To compare the time to treatment failure, remission and first seizure of 12 AEDs
(carbamazepine, phenytoin, sodium valproate, phenobarbitone, oxcarbazepine, lamotrigine …

Epilepsy is one of the most common neurological disorders, affecting approximately 50
million people worldwide. Despite a dramatic increase in treatment options over the past 30 …

Effective treatment of epilepsy depends on medication compliance across a lifetime, and
studies indicate that drug tolerability is a significant limiting factor in medication …

Background In pediatric epilepsy, neurodevelopmental comorbidities could be sometimes
even more disabling than seizures themselves, therefore it is crucial for the clinicians to …

Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data
review - Nevitt, SJ - 2018 | Cochrane Library Skip to Content Cookies Our site uses cookies to …

In this retrospective controlled study, the impact of adjunctive lacosamide (LCM) on
cognition in patients with epilepsy was evaluated and compared with that of topiramate …

Patient tolerability is a significant limiting factor in the treatment of epilepsy and adverse
effect profiles often determine drug retention rates. A full appreciation of the behavioral …

Several newer antiepileptic drugs (AED s) have been introduced into clinical practice,
offering choices for individualizing the treatment of epilepsy since AED s have different …